Stock Movers: McDonald's Consumer Woes, Eli Lilly's Drug Competition, and Qualcomm's Forecast

McDonald's Consumer Sentiment Decline

• 🍟 McDonald's shares fell as US same-store sales dropped 3.6% in Q1, the largest decline since Q2 2020.
• 📉 This downturn is attributed to a deterioration in consumer sentiment, impacting customer traffic despite value offerings and limited-time deals.
• ⚠️ Similar trends were observed at Chipotle and Starbucks, indicating a broader challenge in attracting diners.

Eli Lilly and Weight Loss Drug Market Shifts

• 💊 Eli Lilly's shares dropped after cutting its full-year earnings forecast, despite in-line sales for its weight-loss drug Zepbound.
• 🤝 CVS Caremark partnered with Novo Nordisk to increase availability of Wegovy, a competing weight-loss drug.
• 💸 This deal makes Eli Lilly's Zepbound less preferred and potentially more expensive for insurers and employers using CVS Caremark starting July 1st.
• 🏥 Additionally, CVS's Aetna unit is exiting the Affordable Care Act insurance market in 2026 due to unstable performance.

Qualcomm's Revenue Forecast and Market Concerns

• 📱 Qualcomm shares declined after issuing a revenue forecast below analyst estimates, raising concerns about tariffs impacting smartphone market demand.
• 📉 China, a key market for Qualcomm, and local phone manufacturers are significant customers facing potential tariff effects.
• 📊 This cautious outlook from Qualcomm follows similar warnings from other chipmakers like Intel, suggesting a broader trend in the sector.

Nvidia and Market Drivers

• 🚀 Nvidia shares rose, boosted by strong performance from Microsoft and Meta, which lifted other 'Mag 7' stocks.
• 🗣️ CEO Jensen Huang expressed a desire for the Trump administration to ease regulations on AI technology exports to benefit American businesses.